Skip to content

Effectiveness of a Digital Treatment for Adolescents with Chronic Pain

Effectiveness of a Digital Treatment for Adolescents with Chronic Pain

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06765200
Acronym
DigiDOL-Ad
Enrollment
195
Registered
2025-01-09
Start date
2025-10-31
Completion date
2027-12-31
Last updated
2025-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

chronic pain, mhealth, adolescent, mobile application

Brief summary

Research has shown that the prevalence of chronic pain in adolescents is high and increasing. These young people report significant changes in both their physical and psychological functioning. Currently, psychosocial treatments enjoy strong empirical support and are crucial to maintaining and improving the quality of life of adolescents suffering from chronic pain. However, the availability of these evidence-based interventions is insufficient to meet the high demand, especially outside of large cities. The aim of this project is to develop a digital treatment that helps improve the quality of life of adolescents with chronic pain and complementary websites for their parents and teachers.

Interventions

BEHAVIORALSelf-administered psychosocial intervention delivered via smartphone.

The treatment includes a smartphone-based psychosocial program designed to improve the quality of life of adolescents with chronic pain.

Sponsors

Ministry of Science and Innovation, Spain
CollaboratorOTHER_GOV
University Rovira i Virgili
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* 12-18 years old, * Having a non-oncology secondary chronic pain problem, * Having internet access, * A parent willing to participate in the study, * Providing informed consent/assent.

Exclusion criteria

* Cognitive or language problems

Design outcomes

Primary

MeasureTime frameDescription
Pain intensitybaseline, 8 weeks, 3 months follow-upRefers to the severity of pain an individual experiences, measured on a scale (0-10)
Pain interferencebaseline, 8 weeks, 3 months follow-upRefers to the extent to which pain affects an individual's daily life and functioning. Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Pain Interference will be used (0-32; 0=no interference, 32=intense interference).
Global perception of change after treatment8 weeks, 3 months follow-uprefers to an individual's overall assessment of how their condition has improved or worsened following a treatment, measured on a scale (0-10).

Countries

Spain

Contacts

Primary ContactAriadna Sampietro
ariadna.sampietro@urv.cat+34 977558471

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026